{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:25:31Z","timestamp":1789471531963,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was to explore the association between genetically predicted circulating levels of immunity and inflammation, and the risk of Alzheimer\u2019s disease (AD) and hippocampal volume, by conducting a two-sample Mendelian Randomization Study. We identified 12 markers of immune cells and derived ratios (platelet count, eosinophil count, neutrophil count, basophil count, monocyte count, lymphocyte count, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, CD4 count, CD8 count, CD4-to-CD8 ratio, and CD56) and 5 signaling molecules (IL-6, fibrinogen, CRP, and Lp-PLA2 activity and mass) as primary exposures of interest. Other genetically available immune biomarkers with a weaker a priori link to AD were considered secondary exposures. Associations with AD were evaluated in The International Genomics of Alzheimer\u2019s Project (IGAP) GWAS dataset (21,982 cases; 41,944 controls of European ancestry). For hippocampal volume, we extracted data from a GWAS meta-analysis on 33,536 participants of European ancestry. None of the primary or secondary exposures showed statistically significant associations with AD or with hippocampal volume following <jats:italic>P-<\/jats:italic>value correction for multiple comparisons using false discovery rate\u2009&lt;\u20095% (<jats:italic>Q<\/jats:italic>-value\u2009&lt;\u20090.05). CD4 count showed the strongest suggestive association with AD (odds ratio 1.32, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01, <jats:italic>Q<\/jats:italic>\u2009&gt;\u20090.05). There was evidence for heterogeneity in the MR inverse variance-weighted meta-analyses as measured by Cochran <jats:italic>Q<\/jats:italic>, and weighted median and weighted mode for multiple exposures. Further cluster analyses did not reveal clusters of variants that could influence the risk factor in distinct ways. This study suggests that genetically predicted circulating biomarkers of immunity and inflammation are not associated with AD risk or hippocampal volume. Future studies should assess competing risk, explore in more depth the role of adaptive immunity in AD, in particular T cells and the CD4 subtype, and confirm these findings in other ethnicities.<\/jats:p>","DOI":"10.1038\/s41398-021-01400-z","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T07:03:14Z","timestamp":1621234994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Circulating biomarkers of immunity and inflammation, risk of Alzheimer\u2019s disease, and hippocampal volume: a Mendelian randomization study"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4961-5631","authenticated-orcid":false,"given":"Lana","family":"Fani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios K.","family":"Georgakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0372-8585","authenticated-orcid":false,"given":"M. Arfan","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Kamran","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dichgans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"1400_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13024-018-0284-2","volume":"13","author":"W Cao","year":"2018","unstructured":"Cao, W. & Zheng, H. Peripheral immune system in aging and Alzheimer\u2019s disease. Mol. Neurodegener. 13, 51 (2018).","journal-title":"Mol. Neurodegener."},{"key":"1400_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol."},{"key":"1400_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"1400_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jalz.2018.02.014","volume":"14","author":"SKL Darweesh","year":"2018","unstructured":"Darweesh, S. K. L. et al. Inflammatory markers and the risk of dementia and Alzheimer\u2019s disease: a meta-analysis. Alzheimers Dement. 14, 1450\u20131459 (2018).","journal-title":"Alzheimers Dement."},{"key":"1400_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577, 399\u2013404 (2020).","journal-title":"Nature"},{"key":"1400_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1454-z","volume":"16","author":"KD van der Willik","year":"2019","unstructured":"van der Willik, K. D. et al. Balance between innate versus adaptive immune system and the risk of dementia: a population-based cohort study. J. Neuroinflamm. 16, 68 (2019).","journal-title":"J. Neuroinflamm."},{"key":"1400_CR7","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1136\/bmj.325.7378.1437","volume":"325","author":"GD Smith","year":"2002","unstructured":"Smith, G. D. & Ebrahim, S. Data dredging, bias, or confounding. BMJ 325, 1437\u20131438 (2002).","journal-title":"BMJ"},{"key":"1400_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith, G. D. & Ebrahim, S. \u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol. 32, 1\u201322 (2003).","journal-title":"Int. J. Epidemiol."},{"key":"1400_CR9","doi-asserted-by":"publisher","first-page":"e1001976","DOI":"10.1371\/journal.pmed.1001976","volume":"13","author":"BP Prins","year":"2016","unstructured":"Prins, B. P. et al. Investigating the causal relationship of C-reactive protein with 32 complex somatic and psychiatric outcomes: a large-scale Cross-Consortium Mendelian Randomization Study. PLoS Med. 13, e1001976 (2016).","journal-title":"PLoS Med."},{"key":"1400_CR10","doi-asserted-by":"publisher","first-page":"j5375","DOI":"10.1136\/bmj.j5375","volume":"359","author":"SC Larsson","year":"2017","unstructured":"Larsson, S. C. et al. Modifiable pathways in Alzheimer\u2019s disease: Mendelian randomisation analysis. BMJ 359, j5375 (2017).","journal-title":"BMJ"},{"key":"1400_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/agm2.12046","volume":"1","author":"A Tsui","year":"2018","unstructured":"Tsui, A. & Davis, D. Systemic inflammation and causal risk for Alzheimer\u2019s dementia: Possibilities and limitations of a Mendelian randomization approach. Aging Med. (Milton) 1, 249\u2013253 (2018).","journal-title":"Aging Med. (Milton)"},{"key":"1400_CR12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.cell.2016.10.042","volume":"167","author":"WJ Astle","year":"2016","unstructured":"Astle, W. J. et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell 167, 1415\u20131429 (2016). e1419.","journal-title":"Cell"},{"key":"1400_CR13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ajhg.2018.09.009","volume":"103","author":"S Ligthart","year":"2018","unstructured":"Ligthart, S. et al. Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. Am. J. Hum. Genet. 103, 691\u2013706 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"1400_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13624","volume":"8","author":"DP Hibar","year":"2017","unstructured":"Hibar, D. P. et al. Novel genetic loci associated with hippocampal volume. Nat. Commun. 8, 13624 (2017).","journal-title":"Nat. Commun."},{"key":"1400_CR15","doi-asserted-by":"crossref","unstructured":"Foley, C. N., Kirk, P. D. W. & Burgess, S. MR-Clust: clustering of genetic variants in Mendelian randomization with similar causal estimates. Bioinformatics 37, 531\u2013541 (2021).","DOI":"10.1093\/bioinformatics\/btaa778"},{"key":"1400_CR16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/jhg.2017.76","volume":"62","author":"BD Lin","year":"2017","unstructured":"Lin, B. D. et al. 2SNP heritability and effects of genetic variants for neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio. J. Hum. Genet. 62, 979\u2013988 (2017).","journal-title":"J. Hum. Genet."},{"key":"1400_CR17","doi-asserted-by":"crossref","unstructured":"Georgakis, M. K. et al. Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a Mendelian randomization study. Circ. Genom. Precis. Med. 13, e002872 (2020).","DOI":"10.1101\/19007682"},{"key":"1400_CR18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/hmg\/ddv454","volume":"25","author":"PS de Vries","year":"2016","unstructured":"de Vries, P. S. et al. A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. Hum. Mol. Genet. 25, 358\u2013370 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"1400_CR19","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1161\/CIRCULATIONAHA.109.923383","volume":"121","author":"JP Casas","year":"2010","unstructured":"Casas, J. P. et al. PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry. Circulation 121, 2284\u20132293 (2010).","journal-title":"Circulation"},{"key":"1400_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess, S., Thompson, S. G. & Collaboration, C. C. G. Avoiding bias from weak instruments in Mendelian randomization studies. Int. J. Epidemiol. 40, 755\u2013764 (2011).","journal-title":"Int. J. Epidemiol."},{"key":"1400_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","volume":"100","author":"AV Ahola-Olli","year":"2017","unstructured":"Ahola-Olli, A. V. et al. Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors. Am. J. Hum. Genet 100, 40\u201350 (2017).","journal-title":"Am. J. Hum. Genet"},{"key":"1400_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/CIRCULATIONAHA.118.035905","volume":"139","author":"MK Georgakis","year":"2019","unstructured":"Georgakis, M. K. et al. Genetically determined levels of circulating cytokines and risk of stroke. Circulation 139, 256\u2013268 (2019).","journal-title":"Circulation"},{"key":"1400_CR23","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ije\/dyu005","volume":"43","author":"S Burgess","year":"2014","unstructured":"Burgess, S. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int. J. Epidemiol. 43, 922\u2013929 (2014).","journal-title":"Int. J. Epidemiol."},{"key":"1400_CR24","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658\u2013665 (2013).","journal-title":"Genet. Epidemiol."},{"key":"1400_CR25","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"MF Greco","year":"2015","unstructured":"Greco, M. F., Minelli, C., Sheehan, N. A. & Thompson, J. R. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat. Med. 34, 2926\u20132940 (2015).","journal-title":"Stat. Med."},{"key":"1400_CR26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey, Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304\u2013314 (2016).","journal-title":"Genet. Epidemiol."},{"key":"1400_CR27","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig, F. P., Davey Smith, G. & Bowden, J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int. J. Epidemiol. 46, 1985\u20131998 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"1400_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512\u2013525 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"1400_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14156-4","volume":"11","author":"S Burgess","year":"2020","unstructured":"Burgess, S., Foley, C. N., Allara, E., Staley, J. R. & Howson, J. M. M. A robust and efficient method for Mendelian randomization with hundreds of genetic variants. Nat. Commun. 11, 376 (2020).","journal-title":"Nat. Commun."},{"key":"1400_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693\u2013698 (2018).","journal-title":"Nat. Genet."},{"key":"1400_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jclinepi.2015.08.001","volume":"69","author":"S Burgess","year":"2016","unstructured":"Burgess, S., Butterworth, A. S. & Thompson, J. R. Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors. J. Clin. Epidemiol. 69, 208\u2013216 (2016).","journal-title":"J. Clin. Epidemiol."},{"key":"1400_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/WCO.0b013e328329cf3c","volume":"22","author":"M Kaul","year":"2009","unstructured":"Kaul, M. HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches. Curr. Opin. Neurol. 22, 315\u2013320 (2009).","journal-title":"Curr. Opin. Neurol."},{"key":"1400_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0074-7742(07)79003-7","volume":"79","author":"T Chitnis","year":"2007","unstructured":"Chitnis, T. The role of CD4 T cells in the pathogenesis of multiple sclerosis. Int. Rev. Neurobiol. 79, 43\u201372 (2007).","journal-title":"Int. Rev. Neurobiol."},{"key":"1400_CR34","doi-asserted-by":"publisher","unstructured":"Schooling, C. M., Lopez, P., Yang, Z., Au Yeung, S. L. & Huang, J. V. Bias from competing risk before recruitment in Mendelian Randomization studies of conditions with shared etiology. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/716621 (2019).","DOI":"10.1101\/716621"},{"key":"1400_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1474-4422(19)30435-1","volume":"19","author":"SJ Andrews","year":"2020","unstructured":"Andrews, S. J., Fulton-Howard, B. & Goate, A. Interpretation of risk loci from genome-wide association studies of Alzheimer\u2019s disease. Lancet Neurol. 19, 326\u2013335 (2020).","journal-title":"Lancet Neurol."},{"key":"1400_CR36","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson, P. T. et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142, 1503\u20131527 (2019).","journal-title":"Brain"},{"key":"1400_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/ije\/dyv108","volume":"44","author":"S Burgess","year":"2015","unstructured":"Burgess, S., Timpson, N. J., Ebrahim, S., Davey & Smith, G. Mendelian randomization: where are we now and where are we going? Int. J. Epidemiol. 44, 379\u2013388 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"1400_CR38","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1468-1331.2011.03548.x","volume":"19","author":"A Anand","year":"2012","unstructured":"Anand, A., Gupta, P. K., Sharma, N. K. & Prabhakar, S. Soluble VEGFR1 (sVEGFR1) as a novel marker of amyotrophic lateral sclerosis (ALS) in the North Indian ALS patients. Eur. J. Neurol. 19, 788\u2013792 (2012).","journal-title":"Eur. J. Neurol."},{"key":"1400_CR39","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2174\/156720512803569055","volume":"9","author":"A Anand","year":"2012","unstructured":"Anand, A., Banik, A., Thakur, K. & Masters, C. L. The animal models of dementia and Alzheimer\u2019s disease for pre-clinical testing and clinical translation. Curr. Alzheimer Res. 9, 1010\u20131029 (2012).","journal-title":"Curr. Alzheimer Res."},{"key":"1400_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1871524914666141030145948","volume":"14","author":"K Goyal","year":"2014","unstructured":"Goyal, K., Koul, V., Singh, Y. & Anand, A. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances. Cent. Nerv. Syst. Agents Med. Chem. 14, 43\u201359 (2014).","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"1400_CR41","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jalz.2014.05.1757","volume":"11","author":"International Genomics of Alzheimer\u2019s Disease Consortium","year":"2015","unstructured":"International Genomics of Alzheimer\u2019s Disease Consortium Convergent genetic and expression data implicate immunity in Alzheimer\u2019s disease. Alzheimers Dement. 11, 658\u2013671 (2015).","journal-title":"Alzheimers Dement."},{"key":"1400_CR42","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cell.2016.10.026","volume":"167","author":"L Chen","year":"2016","unstructured":"Chen, L. et al. Genetic drivers of epigenetic and transcriptional variation in human immune cells. Cell 167, 1398\u20131414 (2016). e1324.","journal-title":"Cell"},{"key":"1400_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13195-017-0252-z","volume":"9","author":"YS Hu","year":"2017","unstructured":"Hu, Y. S., Xin, J., Hu, Y., Zhang, L. & Wang, J. Analyzing the genes related to Alzheimer\u2019s disease via a network and pathway-based approach. Alzheimers Res. Ther. 9, 29 (2017).","journal-title":"Alzheimers Res. Ther."},{"key":"1400_CR44","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1016\/j.neurobiolaging.2016.02.024","volume":"41","author":"PG Ridge","year":"2016","unstructured":"Ridge, P. G. et al. Assessment of the genetic variance of late-onset Alzheimer\u2019s disease. Neurobiol. Aging 41, e213\u2013200 (2016). e220.","journal-title":"Neurobiol. Aging"},{"key":"1400_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1017\/thg.2017.3","volume":"20","author":"BD Lin","year":"2017","unstructured":"Lin, B. D. et al. Heritability and GWAS studies for monocyte-lymphocyte ratio. Twin Res. Hum. Genet. 20, 97\u2013107 (2017).","journal-title":"Twin Res. Hum. Genet."},{"key":"1400_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ajhg.2009.12.008","volume":"86","author":"MA Ferreira","year":"2010","unstructured":"Ferreira, M. A. et al. Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control. Am. J. Hum. Genet. 86, 88\u201392 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"1400_CR47","doi-asserted-by":"publisher","first-page":"e0216222","DOI":"10.1371\/journal.pone.0216222","volume":"14","author":"CK Ward-Caviness","year":"2019","unstructured":"Ward-Caviness, C. K. et al. Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease. PLoS ONE 14, e0216222 (2019).","journal-title":"PLoS ONE"},{"key":"1400_CR48","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/eurheartj\/ehr372","volume":"33","author":"H Grallert","year":"2012","unstructured":"Grallert, H. et al. Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies. Eur. Heart J. 33, 238\u2013251 (2012).","journal-title":"Eur. Heart J."},{"key":"1400_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cyto.2013.10.002","volume":"65","author":"AM Matteini","year":"2014","unstructured":"Matteini, A. M. et al. Novel gene variants predict serum levels of the cytokines IL-18 and IL-1ra in older adults. Cytokine 65, 10\u201316 (2014).","journal-title":"Cytokine"},{"key":"1400_CR50","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S2213-8587(15)00034-0","volume":"3","author":"Interleukin 1 Genetics Consortium","year":"2015","unstructured":"Interleukin 1 Genetics Consortium Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis. Lancet Diabetes Endocrinol. 3, 243\u2013253 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1400_CR51","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1093\/hmg\/ddq061","volume":"19","author":"M Barbalic","year":"2010","unstructured":"Barbalic, M. et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum. Mol. Genet. 19, 1863\u20131872 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"1400_CR52","doi-asserted-by":"publisher","first-page":"e1001374","DOI":"10.1371\/journal.pgen.1001374","volume":"7","author":"G Pare","year":"2011","unstructured":"Pare, G. et al. Genome-wide association analysis of soluble ICAM-1 concentration reveals novel associations at the NFKBIK, PNPLA3, RELA, and SH2B3 loci. PLoS Genet. 7, e1001374 (2011).","journal-title":"PLoS Genet."},{"key":"1400_CR53","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/s41588-019-0495-7","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Author Correction: Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat. Genet. 51, 1423\u20131424 (2019).","journal-title":"Nat. Genet."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01400-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01400-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01400-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:08:41Z","timestamp":1669900121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01400-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["1400"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01400-z","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"24 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"291"}}